Summary
Background: Advances in cancer treatment have led to improved long-term survival after childhood cancer, but often at a price of impaired future fertility. Fertility preservation (FP) in male children and early adolescents poses unique challenges as efficacy is unproven.
Objectives: To describe characteristics of testicular tissue cryopreservation (TTCP)
specimens taken from paediatric and adolescent patients, stratified by age, and prior chemotherapy, if any, and to demonstrate evidence for germ cells.
Materials and methods:
Retrospective review of gonadal biopsies and clinical records of patients consented into the Royal Children's Hospital FP programme between 1987 and 2015. Tissue was sliced into blocks, with one section sent for histopathology prior to cryopreservation. In boys ≥12 years where spermatogenesis could be expected, a portion of tissue was disaggregated completely to look for mature sperm and if found, additional tissue was dissected and the resulting suspension frozen.
Results: Testicular tissue cryopreservation specimens in 44 males (0. 3-16.8 years) provided an average of 7.8 slices per patient. All the specimens were taken at the same time as another necessary surgical procedure, under one general anaesthesic. There was only one complication of scrotal wound dehiscence. Seven of the forty-four (15.9%) patients had chemotherapy prior to testicular biopsy, while the rest were chemotherapy naïve. Five of these were prepubertal, and two were pubertal patients.
Eleven subjects had tissue dissected with mature sperm found in eight. Of these eight patients where sperm were found, all were pubertal with testicular size of more than 1 The use of gonadotoxic chemotherapeutic agents such as alkylating agents and/or heavy metals cause dose-related male gonadal dysfunction. 2 The addition of radiation for treatment of cancer significantly increases the risk of gonadal dysfunction. 3 The prepubertal testis is not protected from gonadotoxic treatment, and all exposed germinal epithelium will be lost in the postpubertal boy.
Adolescent boys who have completed puberty have an established method of fertility preservation (FP) through the cryopreservation of mature sperm but this is not possible for prepubertal boys.
Increasingly, testicular tissue cryopreservation (TTCP) is being offered to those prepubertal boys who are at high risk of infertility.
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Methods of fertility preservation are evolving quickly. Little has been published in the endocrinology literature regarding this topic. We report current fertility preservation strategies at the Royal Children's Hospital (RCH), Melbourne, for boys who are undergoing treatment that may impair future fertility. TTCP is offered as an experimental procedure and is undertaken under a three-tier governance structure: 
| METHODS

| RESULTS
Of families who consented to take part in this study, 46 were offered TTCP and two declined. Forty-four boys underwent TTCP. Table 1 shows an overview of all the tissue collected and stored.
Most of these patients had planned treatment that was considered at moderate to high risk of infertility (>30% risk of infertility). Four patients had died (patient 8, 16, 17, 20) , while forty are still alive. Table 2 shows the detailed characteristics of patients who underwent TTCP.
In three boys only a small volume of tissue was removed (<30 mm Thirty-three (75%) of these patients were prepubertal as defined by testicular volumes less than 4 mL. Seven of the forty-four (15.9%) patients had chemotherapy prior to testicular biopsy, while the rest were chemotherapy naïve. Five of these were prepubertal, and two were pubertal patients. One of the pubertal patients had low dose gonadotoxic chemotherapy, while the other had nongonadotoxic chemotherapy prior to TTCP. Both of them went on to receive gonadotoxic therapy subsequently. Details of chemotherapeutic agents that patients received prior to TTCP are provided in Table 3 .
Only one patient had a complication reported postprocedure, a scrotal wound dehiscence occurring 2 weeks after procedure in a patient with aplastic anaemia. He recovered well from this complication with no undue delay in bone marrow transplantation.
In the eleven pubertal patients with potential to freeze sperm suspension, a larger volume of tissue could be taken than in the young prepubertal boys, maximizing their potential for future fertility. There was no delay in the treatment of underlying malignancy or primary pathology.
The pubertal patients had a portion of tissue dissected after collection to look for mature sperm. In three patients, sperm were not found so all remaining tissue was stored as tissue slices. However, mature sperm were found in eight patients. In some of these cases, tissue was stored as a combination of tissue slices and testicular suspension due to low density of the initial sample. All patients with sperm identified were pubertal with testicular size >10 mL and Tanner staging 3+. The youngest patient with sperm found was aged 12.7 years. One patient had prior low-risk gonadotoxic therapy (vincristine, daunorubicin, methotrexate, cytarabine, asparaginase, prednisolone) for acute lymphoblastic leukaemia. Testicular biopsy was performed prior to subsequent administration of cyclophosphamide. All other boys in whom sperm were found were chemotherapy naïve. A 13.6-year-old patient who received cyclophosphamide 2 months before testicular biopsy did not have any sperm found despite good testicular volumes of 12 mL.
| DISCUSSION
Advances in cancer treatment have led to improved long-term survival of children with childhood cancer. The overall 5-year cure rate is now approaching 80% and for Hodgkin's disease it exceeds 90%.
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Preconditioning treatment regimens prior to bone marrow transplantation for nonmalignant conditions such as aplastic anaemia or immunodeficiencies can also involve use of gonadotoxic chemotherapy.
Cyclophosphamide in potentially gonadotoxic doses is also used in treatment of renal diseases such as glomerulonephritis and steroid resistant nephrotic syndrome. hesions, 14 but overall risk is considered very low. In a report of 57 TTCP, there was one postoperative side effect (scrotal cellulitis in a 17 month old who had immunodeficiency). 13 There was no evidence of additional damage when the procedure was carried out for prepubertal boys. 15 In our audit, only one complication of scrotal wound dehiscence occurred, concurring with the literature review findings.
The techniques we used for preparation and cryopreservation of testicular suspensions are based on those used successfully in assisted reproductive treatment in adults. 16, 17 Histology is performed for all specimens to exclude malignancy. This has not been found in any of the specimens in the cohort so far.
Sperm in the ejaculate is a very late phenomenon in the course of spermatogenesis, in terms of pubertal progress and spermarche. 18 The finding of intratesticular sperm is encouraging, giving eight patients in our cohort a real likelihood of future fertility.
Three fertility restoration strategies are currently being studied by others, that is: autotransplantation of a suspension of spermatogonial stem cells (SSCs) by injection into the testis to restore spermatogenesis, autotransplantation of frozen-thawed testicular grafts and growth and maturation of SSCs in vitro. Thus, it is proposed that future use of banked tissue will be variable, with the option of in vitro spermatogenesis for those who have potential risk for tumour cell reintroduction.
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Given the experimental nature of these strategies for fertility restoration currently, it is of paramount importance that parents and patients be counselled that there is no guarantee of success for future fertility and informed consent taken. To avoid potential ethical issues that may arise in case of demise, it should be agreed upon that stored tissue will be discarded in that circumstance. The issue of fertility preservation in children is further complicated by the complexity of obtaining informed consent from parents, assent from minors and with the possibility that parental decisions may not ultimately reflect the patient's wishes when he or she becomes an adult.
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Clinical ethics involvement will help to safeguard the best interests of these children and to ensure that the procedure is offered only to patients where the risk of infertility with treatment is high and the benefit of offering FP outweighs the slight increase in risk with procedure.
As fertility-sparing therapies and fertility-preserving techniques continue to evolve, survivors of childhood cancer and other conditions will have a wider range of choices about fertility. Patients and family are no longer just concerned about preserving their lives but the fullness and quality of it for the future. Clinicians need to recognize that fertility is an important measure of quality of life for many of these survivors and their families. They have a responsibility to keep abreast of advances in this fast evolving field, in order to provide or to refer for sound medical information.
| CONCLUSIONS
Preservation of testicular tissue from today's prepubertal patients may provide fertility restoration in the future, giving hope of fulfilling the human desire for biological offspring. In addition, the retrieval and cryopreservation of mature sperm from peripubertal boys from testicular biopsy confirm the rationale for tissue collection and offers these cases realistic hope for future fertility.
